Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Bremner

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Chemotherapy|January 1, 1983
Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicinD A Bremner
Drugs|January 1, 1977
Antibiotics and skin infections: when to use local or systemic measuresD A Bremner
Chemotherapy|January 1, 1984
Azthreonam activity against gram-negative bacilliD A Bremner
The New Zealand Medical Journal|September 9, 1981
Susceptibility of clinical strains of bacteria to cefoxitinD A Bremner
Pathology|July 1, 1987
Susceptibility of gentamicin sensitive and resistant gram negative bacilli to ceftazidimeD A Bremner
The New Zealand Medical Journal|May 13, 1987
In vitro susceptibility of piperacillin v timentin and ticarcillinD A Bremner
The Journal of Antimicrobial Chemotherapy|October 1, 1985
In-vitro activity of the monobactam Ro 17-2301 against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosaD A Bremner
Journal of Medical Microbiology|August 1, 1979
Transfer of plasmid-mediated antibiotic resistance in strains of Pseudomonas aeruginosa isolated in AucklandD A Bremner
The New Zealand Medical Journal|July 12, 1978
The transfer of antibiotic resistance by R plasmids in ShigellaeD A Bremner
Drugs|January 1, 1981
Susceptibility of clinical isolates to cefoperazoneD A Bremner
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Chemotherapy|January 1, 1983
Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicinD A Bremner
Drugs|January 1, 1977
Antibiotics and skin infections: when to use local or systemic measuresD A Bremner
Chemotherapy|January 1, 1984
Azthreonam activity against gram-negative bacilliD A Bremner
The New Zealand Medical Journal|September 9, 1981
Susceptibility of clinical strains of bacteria to cefoxitinD A Bremner
Pathology|July 1, 1987
Susceptibility of gentamicin sensitive and resistant gram negative bacilli to ceftazidimeD A Bremner
The New Zealand Medical Journal|May 13, 1987
In vitro susceptibility of piperacillin v timentin and ticarcillinD A Bremner
The Journal of Antimicrobial Chemotherapy|October 1, 1985
In-vitro activity of the monobactam Ro 17-2301 against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosaD A Bremner
Journal of Medical Microbiology|August 1, 1979
Transfer of plasmid-mediated antibiotic resistance in strains of Pseudomonas aeruginosa isolated in AucklandD A Bremner
The New Zealand Medical Journal|July 12, 1978
The transfer of antibiotic resistance by R plasmids in ShigellaeD A Bremner
Drugs|January 1, 1981
Susceptibility of clinical isolates to cefoperazoneD A Bremner
Pageof 4